Citations 1
S197: NAVITOCLAX PLUS RUXOLITINIB IN JAK INHIBITOR-NAÏVE PATIENTS WITH MYELOFIBROSIS: PRELIMINARY SAFETY AND EFFICACY IN A MULTICENTER, OPEN-LABEL PHASE 2 STUDY
Foran, James M. , Tandra, A., Stefano, V. De, Mattour, Ahmad, McMullin, M. F., Rodríguez‐Macías, Gabriela , Sibai, Hassan , Qin, Qiuyue, Potluri, Jalaja , Passamonti, Francesco , Stefano, Valerio De , Fox, María Laura , Perkins, Andrew C. , How, Jeffrey
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 98-99
